Rhone Ma Holdings Berhad (KLSE:RHONEMA)

Market Cap	133.84M
Revenue (ttm)	211.60M
Net Income (ttm)	12.30M
Shares Out	221.23M
EPS (ttm)	0.04
PE Ratio	14.83
Forward PE	n/a
Dividend	0.03 (3.91%)
Ex-Dividend Date	Jun 25, 2025

Volume	7,400
Average Volume	16,280
Open	0.6250
Previous Close	0.6400
Day's Range	0.6000 - 0.6250
52-Week Range	0.5800 - 0.8000
Beta	0.27
RSI	49.92
Earnings Date	May 13, 2025

About Rhone Ma Holdings Berhad

Rhone Ma Holdings Berhad, an investment holding company, engages in the manufacture, trading, marketing, and distribution of biotechnology and animal health products primarily in Malaysia. The company provides diagnostic laboratory analysis and consultation services to veterinary, agriculture, and food industries; tests and diagnostics services for human healthcare; and veterinary advisory services. It also conducts research and development in biotechnology; distributes human healthcare and related products; wholesales and distributes pharmaceu...

• Industry: Pharmaceutical Preparations
• Founded: 2000
• Employees: 205
• Stock Exchange: Bursa Malaysia
• Ticker Symbol: RHONEMA

Financial Performance

In 2024, Rhone Ma Holdings Berhad's revenue was 211.60 million, an increase of 4.27% compared to the previous year's 202.93 million. Earnings were 12.30 million, an increase of 1.81%.